Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/4/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Cooper C. Collins

Wrong Cooper C. Collins?

Board Member

Phone: (561) ***-****  HQ Phone
Email: c***@***.com
TherapeuticsMD, Inc.
6800 Broken Sound Parkway Nw Third Floor
Boca Raton , Florida 33487
United States

Company Description: TherapeuticsMD sells to OBGYNs through a direct sales force and has quickly developed relationships with many of the largest OBGYN groups. Physicians then refer...   more
Background

Employment History

Education

  • M.B.A.
    Nicholls State University
  • B.A.
    Nicholls State University
119 Total References
Web References
TherapeuticsMD - Board Members
www.therapeuticsmd.com, 4 July 2014 [cached]
Cooper C Collins: Cooper C. Collins was elected as a Director of TherapeuticsMD, Inc. on February 28, 2012. Mr. Collins was appointed President, Chief Executive Officer and director of Pernix Therapeutics Holdings, Inc. ("Pernix") effective with the close of the merger between Pernix and Golf Trust of America, Inc. on March 9, 2010. Mr. Collins joined Pernix in 2002. He was appointed a director of Pernix in January 2007, Pernix's President in December 2007, and Pernix's Chief Executive Officer in June 2008, serving in those three capacities until the closing of the GTA merger. From December 2005 to December 2007, Mr. Collins served as Vice President of Business and Product Development of Pernix and as Pernix's Territory Manager from December 2003 to December 2005. Over Mr. Collins' tenure as an executive with Pernix, he has been responsible for increasing the overall growth, profitability and efficiency of the organization, overseeing product development and acquisitions, and managing the capital structure of Pernix. Prior to joining Pernix, Mr. Collins was employed for three years by the NFL franchise, The New Orleans Saints, in their media relations department. While on a football scholarship, Mr. Collins received a B.A. from Nicholls State University, where he later received an M.B.A.
...
www.sec.gov, 2 April 2014 [cached]
0001485508 Collins Cooper C. 33219 FOREST WEST DR MAGNOLIA TX 77354 1 Chief Strategic Officer
...
www.sec.gov, 9 June 2014 [cached]
0001485508 Collins Cooper C. 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR BOCA RATON, FL 33487 1 0 0 0
Cooper C. ...
www.sec.gov, 17 April 2014 [cached]
Cooper C. Collins
...
Cooper C. Collins has served as a director of our company since February 2012. Mr. Collins has served as Chief Strategy Officer of Pernix Therapeutics Holdings, Inc. [NASDAQ: PTX], or Pernix, from May 2013 until April 2014, as its President and Chief Executive Officer from March 2010 until May 2013, and as a director from March 2010 until February 2014. Pernix is a specialty pharmaceutical company focused on the sales, marketing, and development of branded and generic pharmaceutical products primarily for the pediatric market. Mr. Collins joined Pernix Therapeutics, Inc., a predecessor of Pernix, in 2002, where he was appointed as a director in January 2007, its President in December 2007, and its Chief Executive Officer in June 2008, serving in those three capacities until March 2010. From December 2005 to December 2007, Mr. Collins served as Vice President of Business and Product Development of Pernix Therapeutics, Inc. and as its Territory Manager from December 2003 to December 2005. Mr. Collins was employed for three years by the National Football League franchise, the New Orleans Saints, in its media relations department. We believe Mr. Collins’ specialty pharmaceutical company knowledge and executive experience provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors. While on a football scholarship, Mr. Collins received a B.A. from Nicholls State University, where he later received an M.B.A.
...
Thompson, Stanicky, Collins, LaPenta, Jr., Musing, and Segal, is an independent director, as “independence” is defined under the applicable rules and regulations of the SEC and the listing standards of the NYSE MKT, because they do not have a relationship with us (either directly or as a partner, stockholder, or officer of an organization that has a relationship with us) that would interfere with their exercise of independent judgment in carrying out their responsibilities as directors.
...
Mr. Collins will be joining the Audit Committee prior to the date of the 2014 Annual Meeting of Stockholders.
...
Collins, Thompson, and Musing, with Mr. Collins serving as Chairman.
...
Collins, Thompson, and Musing, with Mr. Collins serving as Chairman.
...
Collins, Thompson, Musing, and Finizio served as members of the Compensation Committee.
...
Collins, Thompson, or Musing have been at any time one of our officers or employees or had any relationship with us that requires disclosure under Item 404 of Regulation S-K under the Exchange Act.
...
www.sec.gov, 8 Jan 2014 [cached]
0001485508 Collins Cooper C. 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR BOCA RATON FL 33487 1 0 0 0
Other People with the name "Collins":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.